Mengyuan Jiang
Xijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
RND3 Enhances Cardiac Glucose Metabolism Through Inhibiting ACAT1-Dependent PDHA1 Acetylation and Protects Against Ischemia-Reperfusion Injury.
Journal: Circulation
Published: June 11, 2026
Adipsin alleviates cold exposure-induced coronary microvascular dysfunction through a Gα13-dependent mechanism.
Journal: Ecotoxicology and environmental safety
Published: October 28, 2025
Adipsin improves diabetic hindlimb ischemia through SERPINE1 dependent angiogenesis.
Journal: Cardiovascular diabetology
Published: October 10, 2024
Rnd3 protects against doxorubicin-induced cardiotoxicity through inhibition of PANoptosis in a Rock1/Drp1/mitochondrial fission-dependent manner.
Journal: Cell death & disease
Published: July 15, 2024
Single-Cell RNA Sequencing Uncovers Pathological Processes and Crucial Targets for Vascular Endothelial Injury in Diabetic Hearts.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 21, 2024
Rnd3 suppresses endothelial cell pyroptosis in atherosclerosis through regulation of ubiquitination of TRAF6.
Journal: Clinical and translational medicine
Published: June 06, 2023
Eco-friendly chitosan-based nanostructures in diabetes mellitus therapy: Promising bioplatforms with versatile therapeutic perspectives.
Journal: Environmental research
Published: March 21, 2023
Exosomes derived from pericardial adipose tissues attenuate cardiac remodeling following myocardial infarction by Adipsin-regulated iron homeostasis.
Journal: Frontiers in cardiovascular medicine
Published: July 26, 2022
Fibroblast-specific activation of Rnd3 protects against cardiac remodeling in diabetic cardiomyopathy via suppression of Notch and TGF-β signaling.
Journal: Theranostics
Published: July 12, 2022
Last Updated: 09/26/2026